Ascrinvacumab (Anti-ACVRL1 / ALK-1)

Ascrinvacumab (Anti-ACVRL1 / ALK-1) is a human IgG2 monoclonal antibody targeting ALK-1. It can be used for the treatment of hepatocellular carcinoma (HCC), in patients with advanced solid tumors. It also demonstrates its use in antiangiogenic therapy. MW : 150 KD.
Supplier Selleck Chemicals
Product # A2594
Sku # A2594-1mg*5
Pricing 1mg*5, $790.00
Feedback